Jonathan Ruffer: tech stocks have become “long-duration assets”
As with bonds, tech stocks are now held not because of that they are, but because of what investors fear if they don't hold them, says Jonathan Ruffer, chairman of Ruffer Investment Management.
Consider what “the easy route to a successful portfolio in 2020 would have been”, says Jonathan Ruffer, the founder of the £20bn asset manager that bears his name, in his latest letter to investors. First, hold firms such as Amazon “where Covid-19 has blown a mighty following wind”. Second, recognise “that pressure on central banks to cut interest rates further would be irresistible” and buy government bonds before they did so. If you did either, you had a very good year. “But a change in a single variable will sideswipe both those asset classes at the same time. Their dynamics feel very different, but actually, they are not.”
In the eyes of the market, the long-term earnings power of tech stocks has become “more and more valuable” when “discounted at lower and lower interest rates”. They are now “long-duration assets” (ie, their value is very sensitive to changes in interest rates). So their fate will be closely linked to that of bonds.
At this point, investors hold tech because people “fear not holding these stocks”. They hold bonds not for income, but because of “the chess game that plays out between the authorities and the investment community”, under which markets feel they have policymakers trapped “in low-yield (pushing into no-yield) territory”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
When sentiment and circumstances change, so will the calculations that prop up both asset classes. “If inflation comes about – or, rather, looks a realistic possibility – you won’t see government bonds or tech stocks for dust.”
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Tesco braces for supermarket price war with rival Asda
Tesco, Britain’s biggest grocer, has opted to cut its prices more quickly to prevent Asda grabbing market share
By Dr Matthew Partridge
-
Supersonic travel: How China could 'leapfrog' US and Europe's commercial aviation industry
Opinion Innovation in commercial aviation has been stuck for 60 years. A commercial supersonic jet might be back on the market soon, but will China get there first?
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves